methotrexate has been researched along with Child Development Deviations in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krajinovic, M; Marcoux, S; Moghrabi, A; Robaey, P | 1 |
Delatycki, MB | 1 |
Morgan, FC; Whitecar, PW; Yedlinsky, NT | 1 |
Butler, RW; Haser, JK | 1 |
Jannoun, L | 1 |
Britton, PG; Craft, AC; Kernahan, J; Noble, TC; Twaddle, V | 1 |
Battin, M; Chessells, J; Christie, D; Leiper, AD; Neville, BG; Vargha-Khadem, F | 1 |
Kaleita, TA; MacLean, WE; Reaman, GH; Sather, HN; Whitt, JK | 1 |
Bennett, FC; Del Campo, M; Jones, KL; Kosaki, K | 1 |
3 review(s) available for methotrexate and Child Development Deviations
Article | Year |
---|---|
Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy.
Topics: Antineoplastic Agents; Child; Combined Modality Therapy; Cranial Irradiation; Developmental Disabilities; Glucocorticoids; Humans; Methotrexate; Neoplasms; Pharmacogenetics; Polymorphism, Genetic; Risk Factors | 2008 |
Neurocognitive effects of treatment for childhood cancer.
Topics: Antineoplastic Agents; Brain Neoplasms; Child; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Developmental Disabilities; Humans; Injections, Spinal; Intellectual Disability; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2006 |
Developmental delay in fetal aminopterin/methotrexate syndrome.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Aminopterin; Child, Preschool; Developmental Disabilities; Face; Female; Folic Acid Antagonists; Growth Disorders; Humans; Intellectual Disability; Limb Deformities, Congenital; Male; Methotrexate; Pregnancy; Syndrome | 1999 |
6 other study(ies) available for methotrexate and Child Development Deviations
Article | Year |
---|---|
A de novo, apparently balanced reciprocal translocation in a child with developmental delay whose mother was being treated with low-dose methotrexate at the time of conception.
Topics: Adult; Arthritis, Rheumatoid; Developmental Disabilities; Female; Fertilization; Humans; Infant; Maternal Exposure; Methotrexate; Pregnancy; Translocation, Genetic | 2005 |
Anomalies associated with failed methotrexate and misoprostol termination.
Topics: Abortion, Incomplete; Abortion, Induced; Adult; Congenital Abnormalities; Developmental Disabilities; Female; Fetus; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Methotrexate; Misoprostol; Pregnancy; Pregnancy Outcome; Risk Assessment; Ultrasonography, Prenatal | 2005 |
Are cognitive and educational development affected by age at which prophylactic therapy is given in acute lymphoblastic leukaemia?
Topics: Adolescent; Age Factors; Antineoplastic Agents; Brain; Child; Child Behavior Disorders; Child, Preschool; Combined Modality Therapy; Developmental Disabilities; Female; Humans; Infant; Injections, Spinal; Intelligence; Intelligence Tests; Leukemia, Lymphoid; Male; Mental Disorders; Methotrexate; Radiotherapy | 1983 |
Intellectual function after treatment for leukaemia or solid tumours.
Topics: Adolescent; Antineoplastic Agents; Brain; Child; Child, Preschool; Combined Modality Therapy; Developmental Disabilities; Female; Humans; Infant; Injections, Spinal; Intelligence; Intelligence Tests; Leukemia, Lymphoid; Male; Mental Disorders; Methotrexate; Neoplasms; Radiotherapy; Time Factors | 1983 |
Neuropsychological and neurological outcome after relapse of lymphoblastic leukaemia.
Topics: Age Factors; Brain; Child; Child, Preschool; Cognition Disorders; Cranial Irradiation; Developmental Disabilities; Education; Female; Growth Disorders; Humans; Infant; Intelligence; Leukemia, Lymphoid; Leukemic Infiltration; Male; Methotrexate; Nervous System Diseases; Radiation Injuries; Radiotherapy; Recurrence; Whole-Body Irradiation | 1994 |
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Damage, Chronic; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Developmental Disabilities; Female; Follow-Up Studies; Humans; Infant; Injections, Spinal; Leucovorin; Leukemic Infiltration; Male; Mercaptopurine; Methotrexate; Movement Disorders; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Psychomotor Performance; Remission Induction; Risk; Socioeconomic Factors; Survivors; Vincristine | 1999 |